Regulation of iNOS Expression by NF-κB in Human Lens Epithelial Cells Treated With High Levels of Glucose
- 1 July 2013
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 54 (7) , 5070-5077
Abstract
Purpose.: To explore the regulation of inducible nitric oxide synthase (iNOS) expression by nuclear factor kappa B (NF-κB) in human lens epithelial cells (LECs) treated with high levels of glucose, and to elucidate the impact of this in the pathogenesis of cataracts associated with diabetes. Methods.: LECs (SRA01/04) were cultured in vitro. NF-κB nuclear translocation and iNOS expression were measured at different glucose concentrations and at various time points, and the optimal concentration for detecting changes in the patterns of NF-κB nuclear translocation and iNOS expression was chosen. As a specific NF-κB inhibitor, pyrrolidine dithiocarbamate (PDTC) was used to assess the effect of inhibiting NF-κB. Western blotting and inverted fluorescence microscopy were used to monitor the nuclear translocation of NF-κB. PCR and Western blotting were used to measure iNOS expression. Using the University of California, Santa Cruz database and the TFSEARCH program, we searched the DNA sequence upstream of iNOS for the core binding sequence for NF-κB. Chromatin immunoprecipitation (ChIP) was used to measure the binding of NF-κB. Results.: The nuclear translocation of NF-κB was measured upon glucose treatment, and the concentration of NF-κB in the nucleus was found to peak at 25 to 30 minutes of treatment with 25 mM glucose. iNOS mRNA and protein levels also increased significantly in a time- and concentration-dependent manner and iNOS mRNA and protein reached their peak values after 8 hours of treatment with 25 mM glucose. The binding of NF-κB to the promoter of the iNOS gene was enhanced in the 25 mM glucose group compared with the 5.5 mM glucose group or the 25 mM glucose + 100 μL PDTC group, and this difference was statistically significant (P < 0.05). Conclusions.: NF-κB regulates iNOS expression in a time- and concentration-dependent manner. Under high glucose conditions, NF-κB is activated and rapidly translocates to the nucleus, leading to increased binding to the iNOS promoter and a consequent increase in iNOS expression. The findings of this study provide important experimental evidence that clarifies the pathogenesis of cataracts associated with diabetes and contributes to the search for therapeutic targets of these cataracts.Keywords
This publication has 40 references indexed in Scilit:
- Diabetic neuropathy and oxidative stressDiabetes/Metabolism Research and Reviews, 2006
- Increased Sorbitol Pathway Activity Generates Oxidative Stress in Tissue Sites for Diabetic ComplicationsAntioxidants & Redox Signaling, 2005
- The Maillard Reaction in Eye DiseasesAnnals of the New York Academy of Sciences, 2005
- How a jolt and a bolt in a dentist’s chair revolutionized cataract surgeryAmerican Journal of Ophthalmology, 2005
- Effect of Advanced Glycation End Products on Lens Epithelial Cells in VitroBiochemical and Biophysical Research Communications, 2000
- Disruption of α3 Connexin Gene Leads to Proteolysis and Cataractogenesis in MiceCell, 1997
- Progression of diabetic retinopathy and rubeotic glaucoma following cataract surgeryEye, 1995
- Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in humans and animals.Journal of Cell Biology, 1995
- Extracapsular Cataract Extraction in Proliferative Diabetic RetinopathyOphthalmology, 1993
- Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies.British Journal of Ophthalmology, 1993